Free Trial

AstraZeneca (AZN) Short Interest Ratio & Short Volume

AstraZeneca logo
$73.02 -1.07 (-1.44%)
As of 03:58 PM Eastern

AstraZeneca Short Interest Data

AstraZeneca (AZN) has a short interest of 16.97 million shares, representing 0.55% of the float (the number of shares available for trading by the public). This marks a 9.77% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 4.94 million shares to cover all short positions.

Current Short Interest
16,970,000 shares
Previous Short Interest
15,460,000 shares
Change Vs. Previous Month
+9.77%
Dollar Volume Sold Short
$1.29 billion
Short Interest Ratio
3.0 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
3,101,214,000 shares
Short Percent of Float
0.55%
Today's Trading Volume
4,321,311 shares
Average Trading Volume
4,936,343 shares
Today's Volume Vs. Average
88%
Short Selling AstraZeneca?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AstraZeneca and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AZN Short Interest Over Time

AZN Days to Cover Over Time

AZN Percentage of Float Shorted Over Time

Remove Ads

AstraZeneca Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/202516,970,000 shares $1.29 billion +9.8%0.5%3 $76.21
2/15/202515,460,000 shares $1.14 billion -8.7%0.5%2.9 $73.58
1/31/202516,940,000 shares $1.20 billion +12.2%N/A2.8 $70.76
1/15/202515,100,000 shares $991.77 million +19.0%N/A2.5 $65.68
12/31/202412,690,000 shares $831.45 million +26.1%N/A2.3 $65.52
12/15/202410,060,000 shares $669.79 million +36.0%N/A1.8 $66.58
11/30/20247,400,000 shares $500.39 million -8.3%N/A1.4 $67.62
11/15/20248,070,000 shares $510.27 million +74.3%N/A1.5 $63.23
10/31/20244,630,000 shares $329.42 million +14.9%N/A0.9 $71.15
10/15/20244,030,000 shares $313.74 million -25.2%N/A0.9 $77.85
9/30/20245,390,000 shares $419.93 million -16.4%N/A1.2 $77.91
9/15/20246,450,000 shares $504.84 million -27.2%N/A1.5 $78.27
8/31/20248,860,000 shares $776.31 million +4.1%N/A2.1 $87.62
8/15/20248,510,000 shares $722.50 million +49.0%N/A2.1 $84.90
7/31/20245,710,000 shares $451.95 million -1.6%N/A1.4 $79.15
7/15/20245,800,000 shares $453.10 million -9.5%N/A1.4 $78.12
6/30/20246,410,000 shares $499.92 million -19.2%N/A1.4 $77.99
6/15/20247,930,000 shares $631.15 million +18.9%N/A1.6 $79.59
5/31/20246,670,000 shares $520.39 million -13.0%N/A1.3 $78.02
5/15/20247,670,000 shares $590.36 million -10.1%N/A1.4 $76.97
4/30/20248,530,000 shares $647.26 million -0.6%N/A1.3 $75.88
4/15/20248,580,000 shares $589.70 million +12.0%N/A1.4 $68.73
3/31/20247,660,000 shares $518.97 million -26.9%N/A1.2 $67.75
3/15/202410,480,000 shares $694.93 million +13.2%N/A1.7 $66.31
2/29/20249,260,000 shares $594.12 million +3.8%N/A1.5 $64.16
2/15/20248,920,000 shares $560.53 million +117.6%N/A1.4 $62.84
1/31/20244,100,000 shares $273.22 million -29.4%N/A0.7 $66.64
1/15/20245,810,000 shares $403.33 million -6.6%N/A1.1 $69.42
12/31/20236,220,000 shares $418.92 million +8.9%N/A1.1 $67.35
12/15/20235,710,000 shares $370.01 million -27.7%N/A1 $64.80
11/30/20237,900,000 shares $510.26 million -2.5%N/A1.4 $64.59
11/15/20238,100,000 shares $511.35 million -10.1%N/A1.6 $63.13
10/31/20239,010,000 shares $569.70 million +53.8%N/A1.8 $63.23
10/15/20235,860,000 shares $394.55 million -3.9%N/A1.2 $67.33
9/30/20236,100,000 shares $413.09 million -27.2%N/A1.3 $67.72
9/15/20238,380,000 shares $572.10 million +14.3%N/A1.6 $68.27
8/31/20237,330,000 shares $497.12 million +49.0%N/A1.4 $67.82
8/15/20234,920,000 shares $341.99 million -18.7%N/A0.9 $69.51
7/31/20236,050,000 shares $433.79 million -5.2%N/A1.2 $71.70
7/15/20236,380,000 shares $429.88 million -15.9%N/A1.3 $67.38
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
6/30/20237,590,000 shares $543.22 million +27.1%N/A1.7 $71.57
6/15/20235,970,000 shares $445.48 million +22.3%N/A1.4 $74.62
5/31/20234,880,000 shares $356.63 million +4.5%N/A1.2 $73.08
5/15/20234,670,000 shares $350.20 million -19.6%N/A1.2 $74.99
4/30/20235,810,000 shares $425.41 million +44.5%N/A1.3 $73.22
4/15/20234,020,000 shares $296.92 million +6.1%N/A0.8 $73.86
3/31/20233,790,000 shares $263.06 million +21.5%N/A0.8 $69.41
3/15/20233,120,000 shares $201.49 million -10.1%N/A0.6 $64.58
2/28/20233,470,000 shares $226.17 million +28.5%N/A0.7 $65.18
2/15/20232,700,000 shares $188.16 million +8.0%N/A0.6 $69.69
1/31/20232,500,000 shares $163.43 million -50.3%N/A0.5 $65.37
1/15/20235,030,000 shares $357.53 million +18.9%N/A1 $71.08
12/30/20224,230,000 shares $286.79 million -14.2%N/A0.8 $67.80
12/15/20224,930,000 shares $343.82 million +13.3%N/A0.9 $69.74
11/30/20224,350,000 shares $295.67 million -6.7%N/A0.7 $67.97
11/15/20224,660,000 shares $298.01 million -14.3%N/A0.7 $63.95
10/31/20225,440,000 shares $319.93 million -5.6%N/A0.8 $58.81
10/15/20225,760,000 shares $316.63 million +20.8%N/A0.9 $54.97
9/30/20224,770,000 shares $261.59 million -25.7%N/A0.7 $54.84
9/15/20226,420,000 shares $373.26 million -29.4%N/A1 $58.14
8/31/20229,090,000 shares $567.03 million -12.5%N/A1.4 $62.38
8/15/202210,390,000 shares $694.16 million -23.8%N/A1.7 $66.81
7/31/202213,640,000 shares $903.38 million -0.2%N/A2.1 $66.23
7/15/202213,670,000 shares $920.81 million +4.2%N/A2 $67.36
6/30/202213,120,000 shares $866.84 million -11.1%N/A1.9 $66.07
6/15/202214,760,000 shares $894.01 million +36.2%N/A2.1 $60.57
5/31/202210,840,000 shares $720.64 million -34.0%N/A1.6 $66.48
5/15/202216,420,000 shares $1.04 billion +39.7%N/A2.1 $63.14
4/30/202211,750,000 shares $780.20 million +8.6%N/A1.5 $66.40
4/15/202210,820,000 shares $747.12 million +39.4%N/A1.3 $69.05
3/31/20227,760,000 shares $514.80 million -1.7%N/A1 $66.34
3/15/20227,890,000 shares $484.21 million -12.6%N/A1.1 $61.37
2/28/20229,030,000 shares $549.75 million +9.7%N/A1.3 $60.88
2/15/20228,230,000 shares $496.27 million +54.7%N/A1.3 $60.30
1/31/20225,320,000 shares $309.68 million -12.8%N/A1 $58.21
1/15/20226,100,000 shares $358.99 million -1.3%N/A1.3 $58.85
12/31/20216,180,000 shares $359.99 million -1.6%N/A1.4 $58.25
12/15/20216,280,000 shares $349.92 million -16.8%N/A1.3 $55.72
11/30/20217,550,000 shares $413.97 million +8.5%N/A1.4 $54.83
11/15/20216,960,000 shares $416.07 million +2.7%N/A1.3 $59.78
10/29/20216,780,000 shares $422.94 million -5.0%N/A1.3 $62.38
10/15/20217,140,000 shares $429.97 million -0.1%N/A1.2 $60.22
9/30/20217,150,000 shares $429.43 million +9.5%N/A0.7 $60.06
9/15/20216,530,000 shares $368.62 million +1.9%N/A0.7 $56.45
8/31/20216,410,000 shares $373.57 million +14.3%N/A0.6 $58.28
8/13/20215,610,000 shares $328.07 million -25.5%N/A0.5 $58.48
7/30/20217,530,000 shares $431.02 million -94.7%N/A0.7 $57.24
7/15/2021142,900,000 shares $8.14 billion +4.4%N/A14 $56.96
6/30/2021136,940,000 shares $8.20 billion +1.4%5.2%17.4 $59.90
6/15/2021135,110,000 shares $7.95 billion +2.3%5.2%17 $58.84
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
5/28/2021132,060,000 shares $7.50 billion +5.3%5.0%15.5 $56.77
5/14/2021125,410,000 shares $6.90 billion +6.2%N/A12.8 $55.05
4/30/2021118,090,000 shares $6.07 billion +10.1%N/A11.6 $51.37
4/15/2021107,270,000 shares $5.35 billion +8.8%N/A10 $49.84
3/31/202198,560,000 shares $4.93 billion +3.8%N/A9.2 $49.97
3/15/202194,940,000 shares $4.60 billion +10.0%N/A8 $48.42
2/26/202186,280,000 shares $4.22 billion +10.8%N/A6.9 $48.91
2/12/202177,900,000 shares $3.90 billion +18.2%N/A6.4 $50.09
1/29/202165,920,000 shares $3.43 billion +32.0%N/A5.9 $52.04
1/15/202149,930,000 shares $2.56 billion +49.1%N/A4.7 $51.29
11/30/20204,360,000 shares $229.38 million -30.7%N/A0.8 $52.61
11/15/20206,290,000 shares $360.92 million +4.0%N/A1.3 $57.38
10/30/20206,050,000 shares $308.97 million +20.3%N/A1.4 $51.07
10/15/20205,030,000 shares $267.55 million -1.4%N/A1.2 $53.19
9/30/20205,100,000 shares $279.48 million +18.3%N/A0.8 $54.80
9/15/20204,310,000 shares $238.26 million +4.4%N/A0.7 $55.28
8/31/20204,130,000 shares $231.28 million -37.2%N/A0.6 $56.00
8/14/20206,580,000 shares $363.15 million -4.1%N/A1 $55.19
7/31/20206,860,000 shares $382.65 million +453.2%N/A1 $55.78
7/15/20201,240,000 shares $66.94 million -35.4%N/A0.2 $53.98
6/30/20201,920,000 shares $101.59 million -33.1%N/A0.4 $52.91
6/15/20202,870,000 shares $151.08 million -9.5%N/A0.6 $52.64
5/29/20203,170,000 shares $173.08 million -11.0%N/A0.6 $54.60
5/15/20203,560,000 shares $190.14 million -1.4%N/A0.7 $53.41
4/30/20203,610,000 shares $188.73 million -12.2%N/A0.8 $52.28
4/15/20204,110,000 shares $197.40 million -10.9%N/A0.9 $48.03
3/31/20204,610,000 shares $205.88 million -35.7%N/A1 $44.66

AZN Short Interest - Frequently Asked Questions

What is AstraZeneca's current short interest?

Short interest is the volume of AstraZeneca shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 16,970,000 shares of AZN short. 0.55% of AstraZeneca's shares are currently sold short. Learn More on AstraZeneca's current short interest.

What is a good short interest ratio for AstraZeneca?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AZN shares currently have a short interest ratio of 3.0. Learn More on AstraZeneca's short interest ratio.

Which institutional investors are shorting AstraZeneca?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AstraZeneca: Jefferies Financial Group Inc., Wolverine Trading LLC, Squarepoint Ops LLC, Millennium Management LLC, LMR Partners LLP, Jefferies Financial Group Inc., Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Lido Advisors LLC, Optiver Holding B.V., Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Wells Fargo & Company MN, JPMorgan Chase & Co., Simplex Trading LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AstraZeneca?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.55% of AstraZeneca's floating shares are currently sold short.

Is AstraZeneca's short interest increasing or decreasing?

AstraZeneca saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 16,970,000 shares, an increase of 9.8% from the previous total of 15,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does AstraZeneca's short interest compare to its competitors?

0.55% of AstraZeneca's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AstraZeneca: Novo Nordisk A/S (0.30%), Novartis AG (0.25%), Sanofi (0.22%), GSK plc (0.91%), Takeda Pharmaceutical Company Limited (0.14%), argenx SE (3.37%), BioNTech SE (1.19%), Teva Pharmaceutical Industries Limited (2.47%), Summit Therapeutics Inc. (25.07%), Intra-Cellular Therapies, Inc. (2.25%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

What does it mean to sell short AstraZeneca stock?

Short selling AZN is an investing strategy that aims to generate trading profit from AstraZeneca as its price is falling. AZN shares are trading down $0.84 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AstraZeneca?

A short squeeze for AstraZeneca occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AZN, which in turn drives the price of the stock up even further.

How often is AstraZeneca's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZN, twice per month. The most recent reporting period available is February, 28 2025.




This page (NASDAQ:AZN) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners